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Background: Model-based glycaemic control protocols have shown promise in neonatal intensive care 
units (NICUs) for reducing both hyperglycaemia and insulin-therapy driven hypoglycaemia. However, 
current models for the appearance of glucose from enteral feeding are based on values from adult 
intensive care cohorts. This study aims to determine enteral glucose appearance model parameters 
more reflective of premature infant physiology. 
Methods: Peaks in CGM data associated with enteral milk feeds in preterm and term infants are used 
to fit a two compartment gut model. The first compartment describes glucose in the stomach, and the 
half life of gastric emptying is estimated as 20 minutes from literature. The second compartment 
describes glucose in the small intestine, and absorption of glucose into the blood is fit to CGM data. 
Two infant cohorts from two NICUs are used, and results are compared to appearances derived from 
data in highly controlled studies in literature. 
Results: The average half life across all infants for glucose absorption from the gut to the blood was 
50 minutes. This result was slightly slower than, but of similar magnitude to, results derived from 
literature. No trends were found with gestational or postnatal age. Breast milk fed infants were found 
to have a higher absorption constant than formula fed infants, a result which may reflect known 
differences in gastric emptying for different feed types.  
Conclusions: This paper presents a methodology for estimation of glucose appearance due to enteral 
feeding, and model parameters suitable for a NICU model-based glycaemic control context. 
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1.0 Introduction 
In neonatal intensive care hyperglycaemia is a common complication of prematurity [1, 2], and has 
been associated with worsened outcomes [2, 3, 4]. Postnatal growth restriction is a separate, but 
related, problem in premature infants and in extremely low birth weight (ELBW) infants [5]. The 
American Academy of Paediatrics suggests that nutrition goals should aim to achieve a postnatal 
growth rate approximating that of a normal foetus of the same gestational age (GA) [6, 7]. This 
nutrition can be delivered via parenteral or enteral routes, and there is significant debate in literature 
around appropriate onset and clinical procedure for enteral feed initiation [8]. However, enhanced 
nutrition can potentiate and or exacerbate hyperglycaemia. 
While it has been well-established that insulin therapy allows greater glucose tolerance and weight 
gain [9, 10, 11, 12, 13], its effect on other clinical outcomes is not so well-defined. In particular, recent 
glycaemic control trials in the neonatal intensive care unit (NICU) have also suffered significant 
hypoglycaemia [14, 15]. Physiological model-based protocols offer great potential for allowing 
patient-specific care, including the ability to maximise or manage nutrition, and have demonstrated 
safe, effective control in adult and neonatal intensive care units [16, 17]. However, model-based 
methods are only as good as the underlying models ability to capture inter- and intra- patient 
variability [18, 19, 20]. 
Enteral feeding is a very common in many neonatal intensive care units, so a model of glucose 
appearance from enteral feeds is very necessary for model-based tight glycaemic control. Very little 
literature data exists directly quantifying the rate of glucose appearance from intestinal absorption in 
neonates, and is derived from extremely invasive studies involving short sections of intestine [21]. This 
study will develop a model of the appearance of glucose from enteral nutrition. This study does this 
in a minimally invasive manner using retrospective continuous glucose monitor (CGM) data in term 
and premature infants.  In particular, the half-life of gastric absorption of glucose from the gut into 
the bloodstream is determined to better model glucose metabolism in the preterm neonate, and thus 
improve the safety and accuracy of glycaemic control. 
2.0 Methods 
2.1 Two compartment gut model 
A simple two compartment model is used to model glucose transition through the digestive system 
(Figure 1). The model comprises two compartments, P1 and P2, denoting glucose in the stomach and 
intestine, respectively. Glucose is delivered to the stomach as glucose, lactose, or another glucose 
based sugar, and is denoted Pex. The amount [mmol] of glucose in the stomach, P1, is defined: 
𝑃1̇ = 𝑃𝑒𝑥 −  𝑑1𝑃1  (1) 
  
Where 𝑑1 [1/min] describes the rate of gastric emptying. The model thus captures the time delay of 
glucose appearance in the gut due to gastric emptying. Lactose is made up of glucose and galactose in 
roughly equal molar weight, and since galactose does not contribute directly to BG levels it was 
ignored. The amount of glucose in the gut, P2 [mmol], is defined: 
𝑃2̇ = 𝑑1𝑃1 −   min (𝑃𝑚𝑎𝑥, 𝑑2𝑃2 ) (2) 
where d2 [1/min] is the rate constants for glucose uptake from the gut into the blood, respectively. A 
supra-physiological upper limit from of Pmax=6.0 mmol/min is applied [22, 23]. This limit is taken from 
adult models of enteral feeding and glucose modelling [22] in the absence of data for this limit in 
neonates. Equation 2 is thus a function of rate parameters 𝑑1 and 𝑑2, which are not defined for this 
cohort 
2.2 The NICING glucose-insulin model for very premature infants 
The NICING (Neonatal Intensive Care Insulin-Nutrition-Glucose) model for glycaemic control in 
very/extremely preterm neonates is defined [24]: 




𝑃𝐸𝑁(𝑡) + 𝑃𝐸𝑁(𝑡) + 𝐸𝐺𝑃 ∗ 𝑚𝑏𝑜𝑑𝑦 − 𝐶𝑁𝑆 ∗ 𝑚𝑏𝑟𝑎𝑖𝑛
𝑉𝑔,𝑓𝑟𝑎𝑐(𝑡) ∗ 𝑚𝑏𝑜𝑑𝑦
 (3) 
𝐼̇ =  − 
𝑛𝐿𝐼(𝑡)
1 + 𝛼𝐼𝐼(𝑡)
− 𝑛𝐾𝐼(𝑡) − 𝑛𝐼(𝐼(𝑡) − 𝑄(𝑡)) + 
𝑢𝑒𝑥(𝑡)
𝑉𝑃 ∗ 𝑚𝑏𝑜𝑑𝑦
+ (1 − 𝑥𝐿)𝑢𝑒𝑛 (4) 
?̇? = 𝑛𝐼  
𝑉𝑃
𝑉𝑄





𝑚𝑎𝑥(4.2, −1.5 + 1.9 ∗ 𝐺)   
𝑚𝑎𝑥(2.2,−0.37 + 0.86 ∗ 𝐺)
 
     𝑖𝑓 𝑓𝑒𝑚𝑎𝑙𝑒
  𝑖𝑓 𝑚𝑎𝑙𝑒
 (6) 
Parameter values and descriptions are given in Table 1, and the model is shown pictorially in Figure 1. 
All parameters are fixed, with the exception of 𝑆𝐼, which is time varying and fit on an hourly basis from 
clinical data using integral based fitting methods [25]. Further detail on the model and its origin can 
be found in [24] and the online supplement of [26]. This model is structurally similar to the ICING 
model for adults [22], and its dynamics are considered overall reflecting of human glucose-insulin 
dynamics. The NICING model will be used largely unchanged in this analysis for infants ranging from 
very preterm to term, with specific adaptions explained in the next section. It should be noted that 
Table 1 and [24, 26] present parameter values and models for central nervous system (CNS) uptake 
and the fluid volume of the interstitial space (𝑉𝑄) which were originally developer for the 
extremely/very preterm infant (GA: 23 - ~30 weeks). These aspects of the model will be updated to 
account for older infants in the next section. 
 
  
Figure 1: Pictorial representation of the Gut model and its interaction with the NICING pharmaco-
dynamic model. 
 
Table 1: NICING model parameter definitions and values [24].  
Parameter Corresponding physiology Value 
𝑝𝐺  Non-insulin mediated glucose uptake 0.003 min
-1 
𝑆𝐼 Whole body insulin sensitivity Variable [L/mU/min] 
𝛼𝐺 Saturation on insulin-mediated glucose uptake 0.0 [L/mU] 
𝑃𝑇𝑃𝑁(𝑡) Intravenous glucose delivery Variable input [mmol/min] 
𝑃𝐸𝑁(𝑡) Glucose absorption from gut Variable input [mmol/min] 
𝑉𝑔,𝑓𝑟𝑎𝑐(𝑡) Distribution volume of glucose  L/kg 
𝐸𝐺𝑃 Endogenous glucose production  0.033 mmol/kg/min  
𝐶𝑁𝑆 Glucose uptake by central nervous system  0.088 mmol/kg/min 
𝛼𝐼 Saturation on liver clearance of insulin 0.0017 L/mU 
𝑛𝐿 Liver clearance of Insulin 0.39 min
-1 
𝑥𝐿 First pass liver clearance of insulin 0.67 






  [min-1] 




𝑛𝐼 Diffusion of insulin between plasma an 
interstitial spaces 
0.025 min-1 








− 1)  [min-1] 
𝑢𝑒𝑛(𝑡) Endogenous insulin secretion by pancreas Variable – Eq. 6 [mU/L/kg/min] 
𝑢𝑒𝑥(𝑡) Exogenous insulin therapy Variable input [mU /min] 
𝑉𝑃 Fluid volume of plasma 0.047 L/kg 
𝑉𝑄 Fluid volume of interstitial space 𝑉𝑄 = 492 × 𝑃𝑁𝐴−0.09 −  𝑉𝑃 [L/kg] 
𝛼𝐺 Saturation on insulin degradation 0.0 L/mU 
𝑃𝑁𝐴 Post natal age Known Variable [days] 
𝑚𝑏𝑜𝑑𝑦 Body mass Known Variable [kg] 
𝑚𝑏𝑟𝑎𝑖𝑛 Brain mass ~14% of  𝑚𝑏𝑜𝑑𝑦 [28] Estimated Variable [kg] 
 
2.3 Adaptation of the NICING model for preterm and term infants 
The NICING model of glucose - insulin dynamics was developed for very premature infants, but is 
sufficiently reflective of premature and term infant physiology for use here. The only points of change 
were that CNS uptake and interstitial fluid compartment (𝑉𝑄) values were allowed to change with 
gestational age (GA) and post natal age (PNA), by including the literature-based models shown in 
Figure 2. These two dynamics were adapted based on literature data. Other parameters were assumed 
similar for term infants, with no known literature data to provide a basis for change. 
Only two studies were found exploring CNS uptake of glucose, one of which spanned a range of 
gestational and postnatal ages. Figure 2a) shows CNS glucose uptake as a function of conceptual 
gestational age, which is the sum of the gestational age at birth and postnatal age. Older, and likely 
more developed, infants have greater glucose demand from their CNS, particularly after the 40 week 
(term) mark. The model here is defined 
𝐶𝑁𝑆 =  0.0031 ∗ (𝐺𝐴 + 𝑃𝑁𝐴) − 0.0338 (8) 
 
Extracellular fluid volume is important, as interstitial fluid volume is ECV minus plasma volume. 
Extracellular fluid volume proportions change with both gestational and postnatal age, as shown in 
Figure 2b). A literature search of PubMed was performed, expanding on previous work that developed 
a model for extracellular fluid volume based on postnatal age [24]. Key search terms included plasma, 
extracellular, interstitial, fluid volume, and neonate/infant, and 6 studies were found [29, 30, 31, 32, 
33, 34]. Similar to [24], A drop in ECV in the first week following birth is observed across a wide range 
of studies, and is most prominent in the more premature infants.  
An ECV volume model is generated using a linear model derived from [34] to give ECV(PNA=0): 
𝐸𝐶𝑉𝑃𝑁𝐴=0 = −12 × 𝐺𝐴 + 915 (9) 
ECV(PNA>0) is described by a proportional drop off based on two long term studies of ECV in very 
preterm (~28 weeks) [33]  and term (~ 40 weeks) [30] infants. 
𝐸𝐶𝑉𝑓𝑟𝑎𝑐,(GA, PNA) = 𝑖𝑛𝑡𝑒𝑟𝑝(𝐺𝐴, 𝐸𝐶𝑉𝑓𝑟𝑎𝑐,𝐺𝐴=40(PNA), 𝐸𝐶𝑉𝑓𝑟𝑎𝑐,𝐺𝐴=28(PNA)) (10) 
Where interp(x,RX,RY) finds an interpolated solution for x using vectors RX and RY. The fractional drop 
in ECV at weeks 28 and 40 are defined: 






















































































Where vector values are sourced based on literature values from preterm (~28 weeks) [33]  and term 
(~ 40 weeks) [30] infants. 
Finally, the ECV and interstial fluid volume, 𝑉𝑄, are computed: 
𝐸𝐶𝑉 = 𝐸𝐶𝑉𝑓𝑟𝑎𝑐,(GA, PNA) ×  𝐸𝐶𝑉𝑃𝑁𝐴=0   (13) 





                                                                            b) 
Figure 2: Age-adaptive models of a) CNS uptake based on [35, 36], and b) Extracellular fluid 
volume (ECV) based on [29, 30, 31, 32, 33]. Conceptual gestational age is the sum of gestational 
and postnatal age, in weeks. In part b, data points reflect literature results, and the surface 
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2 .4 Parameter Identification 
The rate constant of glucose uptake from the gut into the bloodstream, d2, was the parameter of 
interest. Model-based insulin sensitivity (SI) and glucose appearance from the gut can trade off 
mathematically, so the fitting process was iterative. The parameter d1 was left constant as it also 
trades off with d2, and is thus not practically identifiable without further, unavailable, information 
[37]. Thus,  d1 = 0.035 min-1 (corresponding to a 20 minute half life) is a reasonably acceptable value 
based on existing clinical data [38].  
The gut model of Equations 1 and 2 was fit to CGM data in conjunction with the NICING model 
(Equations 3 – 6), using integral based fitting [25]. This process was iterative, so an initial fit using the 
adult value of d2=0.006 min-1 [22] was carried out to get an initial SI trace (Equation 3). The individual 
d2 values for each feed noted in the clinically charted data were then refit using a grid search (range: 
0.001-0.060 min-1) to minimise RMS error, based on this SI trace. The range of d2 values is chosen to 
limit the fastest half life of absorption to ~10 minutes (d2 = 0.06 min-1). This process was iterated to 
update the SI trace using the median d2 value from the previous iteration. Iterations were continued 
until d2 changed by less than 0.001 (3 decimal places, 2-3 iterations). The time period of CGM data 
fitted over was nominally 150 min (2.5 hours), as this was assumed to approximate the total time for 
glucose appearance from an enteral feed. 
Several factors can confound parameter identification. First, enteral feeds were recorded as having 
been given ‘on the hour,’ whereas, in clinical practice, the actual time of feeds is not perfectly time 
and merely near this mark. For this reason, delivery time of the feed was varied by up to ±20 minutes 
either side of the hour, and the d2 value with the lowest fitting error to the associated glucose peak in 
the CGM data was selected. Second, feed duration is also uncertain, and could vary between 5 and 20 
minutes in this cohort depending on volume and clinical preference. Since this time is not recorded 
delivery duration was assumed as a constant 12min, and sensitivity of d2 to delivery time was 
evaluated separately. 
The resulting parameter d2 was then analysed with respect to PNA, GA, birth weight, and total glucose 
content of feed to assess any additional demographic trend or dependency to for addition to  the 
model. Statistical comparisons are made, where necessary, using the non-parametric Mann-Whitney 
test, and p<0.05 was considered significant.  
2.5 Clinical Data Cohorts  
Enteral feeds were defined as any manually delivered (syringe/feeding tube) enteral nutritional intake 
delivered with duration of ~20min or less, involving expressed breast milk (EBM), nutritionally fortified 
EBM, or milk formula. Breastfeeds were not considered due to uncertainty around the total fluid 
volume delivered, and rate of delivery. Enteral feeds delivered within 2 hours of a breastfeed, a change 
in parenteral (IV) nutrition, or oral dextrose gel use were not used, to avoid any overlapping glucose 
appearance.  
CGM data from enterally fed infants was available in two cohorts: 
Budapest: CGM traces (Guardian REAL-Time, Medtronic Minimed, Northridge, California) from 4 
infants receiving 3 hourly enteral breast milk feeds of 20mL or more were available from Semmelweis 
University, Department of Paediatrics, Hungary. Demographic data are in Table 2. According to the 
local ethical codes this analysis of retrospective CGM data is considered as a clinical data audit, 
requiring only the depersonalization of the data collected. 
SUGAR-BABIES: CGM traces (CGMS system gold, Medtronic Minimed, Northridge, California) from 10 
patients from a cohort of 237 infants who were part of the SUGAR-BABIES study [39] were analysed. 
The SUGAR-BABIES study was approved by the Northern Y Ethics Committee, New Zealand [39]. 
Selection criteria for the N=10 sample size included patients given 10 or more feeds of 10 mL or greater 
volume at least 2 hours apart, with a clear rise and peak in the CGM trace corresponding to the timing 
of an enteral feed. The sample size N = 10 was limited by a pilot data sharing agreement, and patients 
were randomly chosen from the subset that met the criteria above. The patient cohort is summarised 
in Table 2. CGM data for the SUGAR-BABIES study data was recalibrated to blood gas measurements 
of BG concentration using the measured current (ISIG) values and method in Signal, Le Compte [40].  
Recalibration was not carried out for the Budapest data, as not all necessary data was available. 
Table 2: Patient cohort characteristics. Values are median [inter-quartile range]. 
 
Cohort  
Budapest (N=4) SUGAR-BABIES (N=10) 
Gestational Age [wk] 39 [39-40] 36 [35-36] 
Birth Weight [kg] 4.04 [3.58 – 4.65] 2.32 [2.14 – 2.77] 
Hours after birth received 
first feed 
N/A 1.6 [1.3 – 4.4] 
Time after birth CGM was 
inserted 
22 [16-41] days 2.9 [0-6.5] hours 
Enteral feed type 
administered 
(for samples fitted) 
Expressed Breast Milk 
Expressed Breast Milk (N=2) 
Term Formula (N=7) 
Preterm Formula (N=1) 
Per-patient number of feed 
episodes recorded on CGM* 
42 [37 – 45] 28 [21 – 42] 
Total number of feed 
episodes recorded on CGM* 
165 318 
Feed volume [mL]* 75 [70 – 80] 17 [12 – 24] 
*These are feeds that met the selection criteria 
2.6 Reported Absorption Rates for Comparison and Validation 
Glucose absorption rates for short intestinal sections were found in literature. These absorption rates 
were transformed into 'whole compartment' glucose absorption rates by assuming a linear glucose 
gradient down the gut, and integrating to give total glucose present in the gut [mmol].  
Assuming the glucose concentration profile is roughly linear [41] in the gut, then the glucose 
concentration profile is:  
?̌?2 = ?̌?2𝑠 −  𝑚 𝑥 (15) 
Where P2s is the initial glucose concentration.  
Glucose is absorbed over a approximate length of  Lg = 3m [41], and  intestinal radius is r=0.013m for 
adults. Small intestinal length in premature infants gives Lg=0.145m  and r=0.007m for infants [42]. If 









= 𝑑2 𝑐 𝑃2 (17) 
Where P2 is the total glucose in the gut, and is equal to the integral of the glucose concentration across 
the gut. The parameter c is the cross sectional area of the gut (c=π r2). Thus, the total absorption across 



























Equation 8 allows estimation of d2 from intestinal glucose absorption studies in literature. These 
values can then be compared to model identified d2 values to validate the results based on data from 
independent clinical studies.  
  
3.0 Results 
In the Budapest cohort, a d2 solution was converged to in 86 sets of feed data. The median rate 
constant for glucose uptake from the intestines was 0.014 [0.008 - 0.018] min-1, corresponding to an 
absorption half life of 49 [39 - 86] min. A further 79 feed episodes were discarded after visual 
inspection of the data due to CGM error (6%), failure to converge to a solution (12%), failure of feed 
to appear in CGM trace (25%), multiple peaks in expected appearance timeframe causing convergence 
failure (3%), or no initial rise in CGM trace during expected appearance time frame (54%), probably 
reflecting an earlier than recorded onset of feeding.  
For the SUGAR-BABIES cohort, 178 sets of feed data across 10 patients converged to a solution, with 
a median [IQR] rate constant for glucose uptake of d2 = 0.018 [0.012 - 0.026] min-1, which corresponds 
to an absorption half life of 39 [27 - 58] min. In the SUGAR-BABIES cohort a further 140 feed episodes 
were not used due to failure to converge to a solution (12%), failure of the feed to appear in the CGM 
trace (6%), multiple peaks in CGM data during expected appearance time (11%), or a lack of initial rise 
(59%) or subsequent fall (12%) in CGM trace around an expected appearance. The latter two cases, 
totalling 71% of discarded data, are most probably a result of discrepancy between the recorded feed 
time and the given feed time of more than 30 minutes, where ± 20 minutes was assumed in this study. 
The identified glucose absorption rate constant for all CGM data from both cohorts was d2   = 0.014 
[0.008 - 0.022] min-1, corresponding to an absorption half life of 50 [31 -86] min. In Figure 3 it can be 
seen that d2 is similar between cohorts, despite very different feed volumes (Table 2). Median and IQR 
of identified d2  values varied between patients (Figure 4) with high variability over all patient metrics. 
Patient 4, who had the lowest rate constant had GA 36 weeks and birth weight 2.8kg, making no 
different demographically from the average patient in this cohort. There was no clear trend in d2 over 
PNA (R2 < 0.001), BW (R2= 0.03) or feed size (linear R2 = 0.03), where the very low R2 values suggest 
these variables account for little of the variability in the parameter.  Thus, there is significant inter- 
and intra- patient variability in this parameter. 
 
Figure 3: Per patient gut glucose absorption constants (d2) across the SUGAR-BABIES and 
Budapest cohorts. 
 
In the SUGAR-BABIES data, for breast milk feeds (N=57), the median absorption rate constant was d2= 
0.026 [0.018 - 0.035] min-1 (absorption half life of 27 [20 - 39] min) compared to the formula feeds 
(N=118) value of d2= 0.018 [0.010 - 0.020] min-1 (absorption half life of 39 [34 - 69] min), (p<0.001). 
This result may reflect differences in gastric emptying (delay in glucose appearance in the gut) with 
feed type [38]. The remaining 3 feeds were a mixture of breast milk and formula. There is thus a 
significant difference in glucose processing and absorption based on feed type. 
The gut absorption rate constant was, in general, higher with lower gestational age, but the 
relationship was weak (R2 = 0.05), explaining only 5% of the variability. When the SUGAR-BABIES 
formula fed data was divided into groups based on tertiles in GA  and number of feeds (GA>36, GA = 
36, GA>= 36, GA<36 weeks) the gut absorption constant was not significantly different between 
infants grouped by GA (p>=0.06 over all comparisons). Hence, GA is not a significant model factor.  
Figure 4 shows model fit for a representative selection of the converged CGM trace sections from the 
SUGAR-BABIES cohort. It can be seen that the model achieves a qualitatively good fit in most cases. 





















1 2 3 4
Budapest - Patient
addition, there may to be un-modelled appearance dynamics, unrecorded inputs, or sensor error in 
cases where multiple peaks are not captured.  
 
Figure 4: Fitting error over a representative selection of CGM trace sections from SUGAR-BABIES 
data. The crosses (x) show CGM data, and the solid line (-) the model solution around the time of 







































































































Time since feed started [min]
 
Figure 5: Mean RMS fitting error across the d2 range for different feed administration periods over 
the SUGAR-BABIES cohort. 
 
Sensitivity to the time over which the feed was administered was tested, and the results are shown in 
Figure 5. Fitting error does not differ significantly between different assumed administration times. 
Given that blood gas measures of glucose have an associated error of ~2%, the optimum cohort-wide 
d2 can be estimated from Figure 5 to lie between d2 = 0.011 and 0.024 min-1, corresponding to a half 
life of 30 - 70 minutes.  
3.2 Comparison to Reported Absorption Rates 
Only two studies explicitly stating the rate of glucose absorption were  found in the defined PubMed 
literature search for both adults [43] and infants [21] .  These values were converted from a 'per study 
gut length' rate to a whole compartment rate constant using Equation 20, and the results are shown 
in Table 3. The resulting average calculated gut absorption rate constant is higher than the median d2 
values of 0.014 – 0.018 min-1 identified here using CGM data. However, it is approximately the same 
order of magnitude. 
 
Table 3: Intestinal glucose absorption rate constants derived from literature measurements of 






















0.5 66 0.472 0.056 
1.1 133 0.728 0.043 
2.1 260 0.82 0.025 
0.7 66 0.459 0.054 
1.3 133 0.763 0.045 
2.0 200 0.841 0.033 
2.6 260 1.019 0.030 
1.0 66 0.585 0.069 
2.0 133 0.885 0.052 
3.0 200 0.971 0.038 
3.9 260 0.999 0.030 
1.3 66 0.719 0.085 
2.7 133 0.913 0.053 
4.0 200 1.091 0.042 




[1.2 - 2.8] 
133 
[100 - 230] 
0.841 
[0.723 - 0.985] 
0.043 


















0.001 1 0.6 0.047 
0.01 10 3.6 0.028 
0.1 100 27.9 0.022 
Median 0.01 10 3.6 0.028 
 
The trade-off between gut model transport parameters d1 and d2 is shown in Figure 6a. While there is 
a global minimum, the parameters trade off significantly within the middle of their likely physiological 
range. The valleys at either end of the tested range show that so long as at least one dynamic is fast 
enough to achieve adequate appearance, the system is relatively robust to inter-patient variability in 
absorption constants. The global minimum exists in most cases at the upper end of the d1 parameter 
range, suggesting short gastric emptying times, shorter than reported elsewhere in literature. For 
example, in Figure 6a the global minimum occurs at d1 = 0.040, corresponding to a half life of 17 
minutes. In contrast, insulin sensitivity and d2 trade off to a much smaller degree, as shown in Figure 
6b, with relatively small change in SI  for a relatively large change in d2. 
 
Figure 6: a) A typical error surface showing sensitivity and trade off of a) gastric emptying (d1) and 
gut absorption (d2) parameters, and b) gut absorption (d2) and insulin sensitivity (SI) parameters. 
The waterfall plots in a) and b) have have increments d1 = 0.006:0.004:0.038 [1/min] and d2 = 
0.005:0.005:0.025 [1/min] respectively.   
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The kinetics of glucose absorption are relatively scarce in the premature neonate. While gastric 
emptying is relatively well studied [38], intestinal glucose absorption is less well studied, and often 
indirectly assessed. Tracer studies and the appearance of labelled carbon in expired breath has been 
used to estimate overall lactose absorption from a meal over a 9 hour period [44]. Another study 
measured mean lactose ‘digestion and absorption’  to be ~0.7 mg/min/cm, which if the calculations 
and assumptions used for glucose absorption are used (Equation 20 in particular with a perfusion rate 
of 1 mL/min, a perfusion length of 10cm, and a perfusate concentration of 70 g Lactose/L) this 
corresponds to d2 = 0.009/min. 
4.1 CGM derived results 
CGM data was used to estimate whole gut absorption of glucose in premature infants for a 2 
compartment gut model where a delay due to glucose transit of the stomach comprises the first 
compartment, and the second compartment involves glucose in the gut, from which it is absorbed 
into the bloodstream. The identified median gut absorption rate constant for intestinal glucose 
absorption was d2=0.014 min-1, which corresponds to an absorption half life (time for half of total 
glucose to be absorbed) of 50 minutes. This value is twice as fast as the half life of 100 minutes used 
in the adult intensive care case [22].  
The median identified gut absorption constant is of the same order as that calculated from adult and 
infant literature data (0.031 min-1 and 0.028 min-1 respectively, from Table 3), but slightly lower. This 
outcome seems to indicate the results derived from CGM data are physiologically likely, and that gut 
absorption in premature and term infants in intensive care may be lower than that in the literature 
for healthier infants due to their critically ill state, or feed composition differences [38]. Equally, results 
calculated from literature data are extrapolated from highly controlled studies over short lengths of 
bowel, and so may not be fully representative of a whole-compartment absorption rate. 
The kinetics of glucose absorption are relatively scarce in the premature neonate. While gastric 
emptying is relatively well studied [38], intestinal glucose absorption is less well studied, and often 
indirectly assessed. Thus, while d1 can then be estimated from literature, there is little or no 
indications of appropriate values for d2 in literature. This study aimed to estimate this parameter, 
necessary for accounting for enterally administered nutrition during glycaemic control.  
Tracer studies and breath tests have been used to estimate lactose, glucose, or carbohydrate 
absorption from a meal [44, 45]. Indirect glucose and galactose absorption was assessed via plasma 
concentrations of these substrate in another study [46]. As mentioned previously, another study 
measured mean lactose ‘digestion and absorption’ to be ~0.7 mg/min/cm, here was calculated to a 
corresponding d2 = 0.009/min. Other studies have used enzyme activity to measure gut function with 
varying morbidities and degrees of maturity [47, 48, 49, 50]. One study estimated intestinal lactose 
hydrolysation to glucose and galactose to be approximately 80% [47]. Overall, almost none of these 
studies provide data useful for directly quantifying the rate constant for glucose absorption in the 
intestine. Those that the authors are aware of are given in Table 3. 
Gut permeability is a relatively popular topic in literature as it may be related to necrotizing 
enterocolitis. It seems reasonably well established that gut permeability will increase in the first few 
post-natal days [51, 52, 53], but that it decreases with the onset of feeding [53, 54], particularly with 
human milk feeds [54, 55]. Some studies see increased permeability in infants who have not been 
enterally fed, similar to an increased permeability (‘leakiness’) in adults who have been fasted [51]. 
While in theory increased gut permeability results in higher passive absorption of glucose, Rouwet et. 
al [51] report general limited capacity of the gut to absorb monosaccharides in very premature infants, 
with increasing absorptive capacity with increasing postnatal age. Quantitative conclusions from 
literature are made difficult by the use of surrogate measures and the multiple routes for active and 
passive absorption of glucose in the gut. 
Counter to expectations, there were no clear and consistent trends in the absorption constant with 
gestational and post natal age. Enteral feeding of milk causes changes in gut structure and function, 
even in very premature infants [56]. These changes in gut structure and function include changes in 
gut motility,  enzyme secretion, absorptive capacity, and endocrine response  to nutrient absorption 
[56]. Early enteral feeding has been shown to decrease gut atrophy (breakdown of tissues) and 
increase intestinal permeability [51], as well as decreasing the incidence of sepsis [57]. However, 
trends with gestational and postnatal age were not observed, a result that suggests that this method 
for estimating glucose absorption in the gut is indicative only, and not capable of resolving changes in 
gut function within 1 – 3 days. Equally, changes in gut function over this time may fall within inter- 
and intra-patient variability, and these differences may thus be difficult to resolve. Previous studies 
have observed both increasing and decreasing permeability of the neonatal gut to monosaccharide’s 
during the month after birth [51], and permeability may rise and fall over the first couple of weeks of 
life [51]. In the absence of consistent models for changes in gut function with gestational and neonatal 
age, the results derived here are sufficient for model-based control applications.  
The practical insignificance of differences between absorption rate constants over GA and between 
the SUGAR-BABIES data and slightly older Budapest patients with greater feed volume (Table 2) is 
highlighted when blood gas error is considered. Figure 5 shows the RMS error is less than ~2% between 
d2 = 0.011 and 0.023 min-1 (half life 30-63min), suggesting a wide valid range from which the glucose 
absorption can be selected. Almost all median values from groups based on NICU and gestational age 
fall within this range, thus suggesting any observed differences between groups may result from 
chance measurement error. 
Insulin sensitivity and glucose absorption in the gut trade off to a small degree. However, SI is relatively 
insensitive to changes in the gut absorption constant d2 (Figure 6). These results suggest that it is the 
total glucose absorbed, rather than the rate at which it is absorbed, that has the biggest influence on 
hourly insulin sensitivity in this clinically validated model. Thus, while a faster d2 improves model fit to 
the more measurement dense CGM data, variability in d2 does not significantly influence insulin 
sensitivity, and thus glycaemic control [58].    
4.2 Contributions of Gastric Emptying and Feed Composition 
So long as at least one dynamic is fast enough, d1 and d2 trade off. As a result, d1 was fixed constant, 
and a gastric emptying half life of 20 minutes (d1=0.035 min-1) was used. This value is within the range 
of 17 – 60 minutes reported in the review by Bourlieu, Menard [38], where high variation in the rate 
of gastric emptying was seen within and between studies. Some of this variability can be attributed to 
the different gestational ages and feed types used in across the range of studies. In general, gastric 
emptying is slower in more premature infants, and is slower in formula fed infants when compared to 
human breast milk fed infants [38]. Thus, while in this analysis a gastric emptying half life of 20 minutes 
was appropriate for term and premature infants, a longer half life of 30-45 minutes [38] may be more 
appropriate in very and/or extremely premature infants. 
The breast milk fed SUGAR-BABIES cohort lower glucose absorption half lives, indicating faster 
absorption of glucose. This result likely reflects the assumption of a constant gastric emptying over 
the entire cohort. Gastric emptying seems to be dependent on feed types [38], and a relatively faster 
gut absorption constant in the breast milk fed group could reflect a too fast gastric emptying constant 
in the formula fed group. However, as fitting error increased with a higher gastric emptying time, it is 
also possible that milk composition can affect glucose absorption. However, despite this trade off, 
overall appearance of glucose in the blood from enteral feeds is captured by this model. 
In contrast, the glucose absorption rate constant for the breast milk fed Budapest cohort was lower 
than both the formula fed and breast milk fed cohorts. However, the resultant median and inter-
quartile range for this cohort falls within the 2% error region of Figure 5, indicating it may not be 
possible to separate these effects from CGM sensor noise or noise in blood gas measurements. 
Given the wide range of possible glucose absorption rate constant values within the 2% error 
threshold, the study median of d2 = 0.014 1/min is a reasonable approximation of glucose absorption 
dynamics across a wide range of premature infants. This value is also a reasonable approximation of 
glucose absorption in very premature infants, in lieu of more gestational age specific data. However, 
since gastric emptying is known to be slower in very premature infants, the gastric emptying rate 
constant d1 can be tailored to this cohort with a value of d1 = 0.017 min-1, corresponding to a gastric 
emptying half life of 40 minutes.   
4.3 Study Limitations 
There are several limitations to this study. First, CGM data is well known for both sensor noise and 
drift [59, 60, 61, 62]. For each feed, the initial glucose value used was the initial CGM BG value, rather 
than the model fit up to that point, which minimised the effect of sensor drift. In addition, CGM values 
for the SUGAR-BABIES cohort were recalibrated according to the method of [40], which improves the 
correlation between sensor data and BG measures. Around 44-48% of the total feeds in the data failed 
to converge to a solution or failed to display a clear peak in the CGM data around the time expected 
based on the clinical feeding record. In addition, additional blood glucose dynamics, probably 
unrelated to gut function, are evident in some of the examples in Figure 4. As a result, the results in 
this paper should be considered indicative only of glucose absorption, with glucose absorption being 
variable over time and between patients, as might be expected in any case. 
Additionally, infants were selected for this study primarily based on feed volume and number of feeds. 
Thus, infants that were likely to display the largest feed related spikes in CGM data were chosen, and 
so the gut absorption constants found may best reflect relatively large feeds and/or faster absorption, 
the latter of which might skew model-based results. Table 3 shows that the glucose uptake rate is not 
in direct proportion to the gut glucose concentration. The results in this paper display no trend and 
high variability with feed size and glucose concentration, and thus do not confirm, but also, do not 
rule out, different gut absorption constants that vary with different feed sizes. 
A third potential limitation is the use of the NICING model developed for very low birth weight 
premature infants, with the premature and term infant data in this study. Fluid volumes and central 
nervous system uptake were tailored to the infants in this study based on gestational and postnatal 
age. Without the extremely rare C-peptide and plasma insulin data to tailor insulin clearances and 
secretion to this older cohort [63], the NICING model was considered to be sufficiently reflective of 
otherwise similar neonatal physiology for the purposes of this study.  
An upper limit on the rate of glucose absorption (P_max in Equation 2) was estimated from that 
used in an adult ICU model [22] due to a lack of comprehensive and quantitative data for this limit in 
neonates. As the glucose absorption rates observed in this study are much lower than this upper 
limit, currently P_max acts as a rarely used limit at the upper end of what might be physiologically 
expected. This provides consistency and safety in the model-based approach for extreme cases or 
erroneous data entry, without affecting model dynamics.  
In addition, while the calculated absorption rate constants agree broadly with others published in 
literature, they were calculated within the context of the NICING model, and should thus be used with 
caution outside of this context. Many of the parameters of the NICING model, which can be found in 
Table 1, are fixed, and thus the glucose absorption rate constant calculated here may change slightly 
were these values to change. Parameter sensitivity for the glucose-insulin kinetics with SI has been 
examined elsewhere [24, 64, 65].  However, given that the glucose absorption constant is 
predominately a function of the size of glucose appearance peaks, and that no other dynamic in the 
glucose-insulin model has this shape, parameter trade-off with other NICING model parameter is not 
expected to be significant. 
Finally, the CGM data in this study is from older infants than those the gut absorption model is being 
designed for. This difference is perhaps partly offset through the use of the NICING model. However, 
given the lack of such CGM data being available for very or extremely premature infants, the results 
are considered more indicative of premature infant gut glucose absorption than that of adult ICU 
patients.  
Overall, these results are sufficient for an estimation of the gut glucose absorption rate constant, but 
should be interpreted with caution outside the context of this study and the NICING model. However, 
they provide a foundation for further specific studies given this is a first modelling attempt with the 
benefit of CGM data and the results are in line with expected values. 
 
5.0 Conclusions 
CGM data has been used to estimate the half life, and therefore the rate constant, of glucose 
absorption from the gut to the bloodstream. The median gut absorption rate constant was d2 = 0.014 
min-1, which corresponds to an absorption half life of 50 minutes. There was no significant trend or 
difference in this constant with gestational or postnatal age, particularly when measurement error in 
blood glucose is considered. There was a difference between absorption constants in feed formula or 
breast milk fed infants feed, but this study cannot resolve whether this is due to differences in gastric 
emptying or gut absorption based, or both.  Overall, this paper presents a method for estimating 
glucose absorption using CGM data for use in a model-based glycaemic control framework. 
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